Internal Medicine, Hematology & Oncology · New York, NY
NPI
1255333811
Since 2005
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
0
Medicare group memberships
Hospitals
2
Hospital affiliations
1050 Park Ave, Suite 1c
New York, NY, 10028
Phone (212) 828-4000
Medicare paid, 2024
$1.3M
80,693 services
Medicare patients, 2024
478
Average age 78
Drug cost, 2024
$1.7M
2,126 prescriptions
Company payments, 2023
$19.81
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Anna M Gattani was code J2469 (injection, palonosetron hcl, 25 mcg), 4,020 times for 29 patients. In total Anna M Gattani billed 80,693 services in 75 codes, and Medicare paid $1.3M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-02-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 4,020 | 29 | $0.71 | $2,873 |
| J0461 Injection, atropine sulfate, 0.01 mg | Office | 3,960 | 11 | $0.07 | $258 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 3,584 | 26 | $0.09 | $320 |
| J0897 Injection, denosumab, 1 mg | Office | 3,180 | 33 | $20.72 | $66K |
| 85025 Blood Count | Office | 1,574 | 462 | $7.61 | $12K |
| 99214 Office E&M - Established | Office | 1,260 | 445 | $112.17 | $141K |
| 36415 Venipuncture Blood Collection | Office | 1,105 | 450 | $8.65 | $9,558 |
| J9206 Injection, irinotecan, 20 mg | Office | 863 | 11 | $2.14 | $1,845 |
| 96367 Intravenous Infusion, Hydration | Office | 715 | 49 | $26.57 | $19K |
| 96375 Injection Administration | Office | 499 | 29 | $14.46 | $7,214 |
| 96413 Chemotherapy Administration | Office | 498 | 44 | $124.26 | $62K |
| J2916 Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg | Office | 461 | 11 | $1.75 | $807 |
| 96417 Chemotherapy Administration | Office | 456 | 24 | $61.31 | $28K |
| 99213 Office E&M - Established | Office | 448 | 161 | $80.29 | $36K |
| J9201 Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg | Office | 378 | 13 | $2.65 | $1,000 |
By year: 2022 $1.7M for 109,777 services; 2023 $1.5M for 96,685 services; 2024 $1.3M for 80,693 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 1,574 | 462 | $7.61 | $12K |
| 36415 Venipuncture Blood Collection | 1,105 | 450 | $8.65 | $9,558 |
| 81002 Clinical Chemistry | 301 | 192 | $3.41 | $1,026 |
Medicare prescription drug claims, 2024
In 2024, the drug Anna M Gattani prescribed most often to Medicare patients was Letrozole, with 190 prescriptions and refills. In total Anna M Gattani wrote 2,126 Medicare prescriptions that cost $1.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Letrozole Generic | 190 | 529 | 54 | $4,509 |
| Levothyroxine Sodium Generic | 144 | 414 | 47 | $2,280 |
| Atorvastatin Calcium Generic | 143 | 387 | 45 | $1,501 |
| Rosuvastatin Calcium Generic | 86 | 233 | 31 | $1,641 |
| Zolpidem Tartrate Generic | 71 | 71 | 13 | $583 |
| Alprazolam Generic | 65 | 65 | 16 | $673 |
| Losartan Potassium Generic | 50 | 150 | 16 | $914 |
| Metformin Hcl Generic | 50 | 127 | 15 | $621 |
| Lorazepam Generic | 45 | 45 | 11 | $237 |
| Escitalopram Oxalate Generic | 43 | 103 | 13 | $423 |
| Metoprolol Succinate Generic | 43 | 105 | 12 | $916 |
| Simvastatin Generic | 43 | 125 | 15 | $588 |
| Raloxifene Hcl Generic | 41 | 99 | 11 | $1,487 |
| Synthroid Levothyroxine Sodium | 39 | 114 | 11 | $3,394 |
| Amlodipine Besylate Generic | 37 | 111 | 14 | $488 |
Brand drugs: - claims; generic drugs: 1,802 claims; opioid claims: 25.
Money and other things of value reported by the companies
In 2023, drug and medical device companies paid Anna M Gattani $19.81 ($19.81 in general payments such as food, travel and fees) from 1 company. The largest payer was Merck Sharp & Dohme LLC with $19.81.
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC MRK | 1 | $19.81 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.